Increased risk of sudden sensory neural hearing loss in osteoporosis: A longitudinal follow-up study
Journal of Clinical Endocrinology & Metabolism | Aug 12, 2018
ACTIVExtend: 24 months of alendronate after 18 months of abaloparatide or placebo for postmenopausal osteoporosis
Journal of Clinical Endocrinology & Metabolism | Aug 12, 2018